丝素微针持续释放模拟感染增强流感疫苗免疫原性与效力
传统推注接种使疫苗从淋巴组织快速清除,而抗原递送动力学可影响免疫应答。本研究开发丝素微针阵列贴片(MIMIX),在皮肤内持续释放抗原1-2周以模拟自然流感感染时间进程。临床前小鼠模型中,单次MIMIX接种较肌注诱导更快血清转换、与初免-加强推注免疫应答等效、对漂移株HAI滴度更高且致死攻击保护效力更优。
要点
- MIMIX丝素微针贴片可在皮内持续释放流感疫苗抗原1-2周。
- 小鼠单次MIMIX接种的血清转换快于肌注,应答与初免-加强推注等效。
- MIMIX接种对漂移流感株HAI滴度更高,致死攻击保护效力更优。
核心结论
- 通过丝素微针持续释放模拟感染的免疫策略可增强季节性流感疫苗的体液应答 magnitude、持久性与广度。
研究设计与样本
- 临床前小鼠模型研究,比较MIMIX丝素微针贴片单次接种与肌注推注接种的免疫应答与保护效力。
主要发现
- 单次MIMIX接种较肌注出现更快血清转换。
- 单次MIMIX接种应答与初免-加强推注免疫等效。
- MIMIX接种对漂移流感株HAI滴度更高。
- MIMIX接种在致死流感攻击中保护效力更优。
临床怎么用
- 提示持续释放微针贴片平台可能用于改善现有季节性流感疫苗的免疫效果。
局限性
- 证据来自临床前小鼠模型,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Traditional bolus vaccine administration leads to rapid clearance of vaccine from lymphoid tissue. However, there is increasing evidence suggesting that the kinetics of antigen delivery can impact immune responses to vaccines, particularly when tailored to mimic natural infections. Here, we present the specific enhancements sustained release immunization confers to seasonal influenza vaccine, including the magnitude, durability, and breadth of humoral responses. To achieve sustained vaccine delivery kinetics, we have developed a microneedle array patch (MIMIX), with silk fibroin-formulated vaccine tips designed to embed in the dermis after a short application to the skin and release antigen over 1-2 weeks, mimicking the time course of a natural influenza infection. In a preclinical murine model, a single influenza vaccine administration via MIMIX led to faster seroconversion, response-equivalence to prime-boost bolus immunization, higher HAI titers against drifted influenza strains, and improved protective efficacy upon lethal influenza challenge when compared with intramuscular injection. These results highlight infection mimicry, achieved through sustained release silk microneedles, as a powerful approach to improve existing seasonal influenza vaccines, while also suggesting the broader potential of this platform technology to enable more efficacious next-generation vaccines and vaccine combinations.
引用
- Stinson JA, Boopathy AV, Cieslewicz BM, et al. Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles. Vaccine. 2021. PMID: 34391593. doi:10.1016/j.vaccine.2021.07.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。